CliffBio
small molecule

NUMORPHAN

OXYMORPHONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyEndo Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameNUMORPHAN
Active ingredientOXYMORPHONE HYDROCHLORIDE
Strength5MG
Dosage formSUPPOSITORY
RouteRECTAL
ModalitySmall molecule
Marketing statusDISCN

More from Endo Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NUMORPHAN patent cliff — loss of exclusivity — | CliffBio